Nemetschek’s Market Nemesis: Strong Q1 Growth and a $2.4B Acquisition Can’t Lift a Stock Under Siege
28.06.2026 - 16:07:22 | boerse-global.de
The German software group Nemetschek finds itself caught in a peculiar bind. Its first-quarter numbers are solid by any conventional measure – revenue up 17% on a currency-adjusted basis to €313.1 million, EBITDA climbing nearly 30% to €98.4 million, and a recurring revenue share now above 92%. Yet the stock has shed roughly 42% since the start of the year and closed Friday at €52.60, a mere 4.26% above a fresh 52-week low of €50.45 reached on June 26.
Investors are simply not buying the story. Even a major strategic move – the acquisition of US infrastructure software specialist HCSS for around $2.4 billion – has failed to ignite enthusiasm. Nemetschek will take a 72% stake in the business, which generated about $215 million in revenue in 2025, while private equity firm Thoma Bravo retains the remaining 28%. The deal is expected to close in the second half of 2026. Adding to the corporate activity, Nemetschek also picked up a minority stake in French data specialist Dawex on June 18, positioning itself for secure data exchange platforms relevant to agentic AI in construction.
Analyst Divergence Grows Wider
The sell-side is split. Jefferies recently trimmed its price target from €90 to €70, citing a subdued outlook for European software in the second quarter, but kept a buy recommendation. Berenberg, in a note on June 19, reaffirmed its “buy” rating with a bold target of €115. LBBW also sees value at €91. The consensus median target stands at €90.50.
UBS offers a stark counterpoint: a “sell” rating with a target of just €56 – barely above the current share price. That gap in opinion reflects a deeper unease among some investors about the impact of artificial intelligence on traditional software providers. As Berenberg analyst Nay Soe Naing summed up, stable growth and a solid order book are no longer enough to draw buyers when the market is fixated on AI winners and losers.
Should investors sell immediately? Or is it worth buying Nemetschek?
Technical Picture Shows Strain
Technically, the shares are under pressure. The 200-day moving average sits at €78.78, a full 33% above the current level. The 50-day moving average at €61.45 also marks a significant hurdle. The relative strength index (RSI) is at 34.5, flirting with oversold territory but not yet triggering a decisive reversal.
The €50.45 mark is the critical floor. A clean break below that would open the door to further losses, while any bounce from that level would at least signal short-term stabilization. But with few company-specific catalysts before July 30, short-term direction depends heavily on macro data – particularly the Eurostat inflation flash estimate for June on July 1 and the US jobs report a day later, both of which could influence rate-sensitive growth stocks like Nemetschek.
All Eyes on July 30
The next big inflection point is the half-year report on July 30. That is when management must address how the HCSS acquisition will be integrated into the full-year outlook. Will the guidance for 14% to 15% revenue growth and an EBITDA margin of 32% to 33% be maintained, or could it be revised upward to reflect the deal’s contribution? The answer will likely shape the stock’s trajectory far more than any short-lived technical bounce.
Nemetschek at a turning point? This analysis reveals what investors need to know now.
For now, Nemetschek’s operational strength is being drowned out by macro uncertainty and AI-related skepticism. The market wants proof that a traditional software house can thrive in a generative world – and it is not yet willing to give the company the benefit of the doubt.
Ad
Nemetschek Stock: New Analysis - 28 June
Fresh Nemetschek information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
